Sirak Igor, Pohanková Denisa, Kašaová Linda, Hodek Miroslav, Motyčka Petr, Asqar Ahmed, Grepl Jakub, Paluska Petr, Novotná Veronika, Vosmik Milan, Petera Jiri
Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.
Clinic of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Rep Pract Oncol Radiother. 2024 Jun 6;29(2):155-163. doi: 10.5603/rpor.99907. eCollection 2024.
The optimal radiotherapy technique for cardiac sparing in left-sided early breast cancer (EBC) is not clear. In this context, the aim of our dosimetric study was to compare cardiac and lung doses according to the type of radiotherapy - whole breast irradiation (WBI), external partial breast irradiation (PBI), and multicatheter interstitial brachytherapy-accelerated partial breast irradiation (MIB-APBI). The dosimetric results with the WBI and PBI were calculated with and without DIBH.
Dosimetric study of 23 patients treated with WBI, PBI, with and without DIBH, or MIB-APBI. The prescribed dose was 40 Gy in 15 fractions for WBI and PBI and 34 Gy in 10 fractions (bid) for MIB-APBI. Doses to the organs-at-risk (OAR) - heart, left anterior descending coronary artery (LAD), left ventricle (LV), and left lung - were recalculated to the equivalent dose in 2-Gy fractions (EQD2).
The addition of DIBH significantly reduced EQD2 doses to all OARs (except for the left lung maximal dose) in WBI and PBI. MHD values were 0.72 Gy for DIBH-WBI, 1.01 Gy for MIB-APBI and 0.24 Gy for DIBH-PBI. There were no significant differences in cardiac doses between WBI with DIBH and PBI without DIBH. DIBH-PBI resulted in significantly lower mean doses to all OARs (except for maximum lung dose) compared to MIB-APBI. Conclusions: These results show that the use of DIBH significantly reduces cardiac doses in patients with left EBC. Partial irradiation techniques (PBI, MIB-APBI) significantly reduced cardiac doses due to the smaller clinical target volume. The best results were obtained with DIBH-PBI.
左侧早期乳腺癌(EBC)中实现心脏保护的最佳放疗技术尚不清楚。在此背景下,我们剂量学研究的目的是根据放疗类型——全乳照射(WBI)、外照射部分乳腺照射(PBI)和多导管组织间插植近距离放疗加速部分乳腺照射(MIB-APBI)——比较心脏和肺部剂量。WBI和PBI的剂量学结果在有和没有深吸气屏气(DIBH)的情况下进行计算。
对23例接受WBI、PBI(有和没有DIBH)或MIB-APBI治疗的患者进行剂量学研究。WBI和PBI的处方剂量为40 Gy分15次,MIB-APBI为34 Gy分10次(每日两次)。对危及器官(OAR)——心脏、左前降支冠状动脉(LAD)、左心室(LV)和左肺——的剂量重新计算为2 Gy分次的等效剂量(EQD2)。
在WBI和PBI中,DIBH的加入显著降低了所有OAR的EQD2剂量(左肺最大剂量除外)。DIBH-WBI的平均心脏剂量(MHD)值为0.72 Gy,MIB-APBI为1.01 Gy,DIBH-PBI为0.24 Gy。有DIBH的WBI和没有DIBH的PBI之间心脏剂量无显著差异。与MIB-APBI相比,DIBH-PBI导致所有OAR的平均剂量显著降低(最大肺剂量除外)。结论:这些结果表明,DIBH的使用显著降低了左侧EBC患者的心脏剂量。部分照射技术(PBI、MIB-APBI)由于临床靶体积较小,显著降低了心脏剂量。DIBH-PBI取得了最佳结果。